MedPath

ReSure Sealant Pivotal Study

Phase 3
Completed
Conditions
Cataract Surgery Incision Leak
Interventions
Procedure: Sutures
Device: ReSure Sealant
Registration Number
NCT01498224
Lead Sponsor
Ocular Therapeutix, Inc.
Brief Summary

This is a randomized multicenter study to evaluate the safety and effectiveness of ReSure Sealant compared to sutures for preventing incision leakage within the first 7 days of cataract surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
488
Inclusion Criteria
  • Subject has a cataract and is expected to undergo clear cornea cataract surgery with phacoemulsification and implantation of posterior chamber intraocular lens
  • Subject must be 22 years of age or older
Exclusion Criteria
  • Any intraocular inflammation in study eye or presence of ocular pain in operative eye at preoperative assessment
  • Previous corneal or retinal surgery or planned multiple procedures during cataract surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SutureSuturesSuture application
ReSure SealantReSure SealantSealant application
Primary Outcome Measures
NameTimeMethod
Proportion of eyes with any clear corneal incision/suture leakage as determined by positive Seidel test indicating fluid egress within first 7 days after surgery.Days 1-28
Secondary Outcome Measures
NameTimeMethod
Foreign Body SensationDays 1-28
Best corrected visual acuityDay 28

Best corrected visual acuity worse than 20/40 at 28 days

Trial Locations

Locations (1)

Levenson Eye Associates

🇺🇸

Jacksonville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath